Prolonged Enoxaparin In Primary Percutaneous Coronary Intervention; A Pilot Pharmacodynamic Study

NCT03146858 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

22

Enrollment

OTHER

Sponsor class

Conditions

Primary Percutaneous Coronary Intervention

Interventions

DRUG: Enoxaparin

Sponsor

Sheffield Teaching Hospitals NHS Foundation Trust